KERI MAIZAN: Open Payments
NPI 1992192892 · CLARKSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 38 payments from 10 companies in 2025. Trend: 2023 $628 · 2024 $528 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 11 | $282 |
| Astellas Pharma US Inc | 10 | $227 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $83 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $71 |
| MILLICENT US INC | 3 | $52 |
| Exeltis, USA Inc. | 3 | $49 |
| ABBVIE INC. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Boston Scientific Corporation | 1 | $14 |
Products named: ZURZUVAE, Veozah, Mirena, SLYND, INTRAROSA, QULIPTA, FEMRING, ABRYSVO.
Industry payments across TN — which companies pay providers there.
